| Pharmaceutical active ingredients: |
| Dihydroergocristine MesylateDihydroergotamine MesylateRaubasine Hydrochloride |
| Available forms, composition and doses of Vasofluina: |
| N / A |
| Vasofluina medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE54 - Dihydroergocristine, combinationsN02CA51 - Dihydroergotamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Zambon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Iskemil | Dihydroergocristine Mesylate | Ache Laboratorios Farmaceuticos |
| Iskevert | Dihydroergocristine Mesylate | Eversil Produtos Farmaceuticos Industria e Comercio |
| Nehydrin | Dihydroergocristine Mesylate | TAD Pharma; Sanochemia Pharmazeutika |
| Unergol | Dihydroergocristine Mesylate | Poli Industria Chimica |
| Vasoton | Dihydroergocristine Mesylate | NCSN Farmaceutici |
| Defluina | Dihydroergocristine Mesylate; Dihydroergotamine Mesylate; Raubasine; Raubasine Hydrochloride | Ebewe |
| Anavenol | Dihydroergocristine Mesylate; Esculoside; Rutin | Zentiva |
| Sandoven | Dihydroergocristine Mesylate; Esculoside; Rutin | Novartis; Sandoz |
| Sandovene F | Dihydroergocristine Mesylate; Esculoside; Rutin | Sandoz |
| Ersilan | Dihydroergocristine Mesylate; Etofylline | IVAX |